Consistent with this, studies in APOE-targeted replacement (APOE-TR) mice demonstrate that aging alone can induce upregulation of DAM/MGnD genes and enrichment of DAM-like microglia against an APOEε4 background, independent of AD pathology [77]. This evidence concerns the gene APOE and Alzheimer disease.